Global Retinal Drugs and Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Retinal Drugs and Biologics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Retinal Drugs and Biologics industry chain, the market status of Hospitals (Age Related Macular Degeneration, Diabetic Retinopathy), Clinics (Age Related Macular Degeneration, Diabetic Retinopathy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Retinal Drugs and Biologics.
Regionally, the report analyzes the Retinal Drugs and Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Retinal Drugs and Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Retinal Drugs and Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Retinal Drugs and Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Age Related Macular Degeneration, Diabetic Retinopathy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Retinal Drugs and Biologics market.
Regional Analysis: The report involves examining the Retinal Drugs and Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Retinal Drugs and Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Retinal Drugs and Biologics:
Company Analysis: Report covers individual Retinal Drugs and Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Retinal Drugs and Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Retinal Drugs and Biologics. It assesses the current state, advancements, and potential future developments in Retinal Drugs and Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Retinal Drugs and Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Retinal Drugs and Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Retinal Drugs and Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Retinal Drugs and Biologics, with price, sales, revenue and global market share of Retinal Drugs and Biologics from 2019 to 2024.
Chapter 3, the Retinal Drugs and Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Retinal Drugs and Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Retinal Drugs and Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Retinal Drugs and Biologics.
Chapter 14 and 15, to describe Retinal Drugs and Biologics sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Retinal Drugs and Biologics industry chain, the market status of Hospitals (Age Related Macular Degeneration, Diabetic Retinopathy), Clinics (Age Related Macular Degeneration, Diabetic Retinopathy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Retinal Drugs and Biologics.
Regionally, the report analyzes the Retinal Drugs and Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Retinal Drugs and Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Retinal Drugs and Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Retinal Drugs and Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Age Related Macular Degeneration, Diabetic Retinopathy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Retinal Drugs and Biologics market.
Regional Analysis: The report involves examining the Retinal Drugs and Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Retinal Drugs and Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Retinal Drugs and Biologics:
Company Analysis: Report covers individual Retinal Drugs and Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Retinal Drugs and Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Retinal Drugs and Biologics. It assesses the current state, advancements, and potential future developments in Retinal Drugs and Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Retinal Drugs and Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Retinal Drugs and Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Age Related Macular Degeneration
- Diabetic Retinopathy
- Ocular Inflammatory Disease (Uveitis)
- Macular Hole
- Hospitals
- Clinics
- Others
- ALLERGAN
- AbbVie
- Alimera Sciences
- Janssen Biotech
- Swedish Orphan Biovitrum
- Roche
- Bristol-Myers Squibb
- Genzyme
- Genentech
- OCULAR THERAPEUTIX
- Bausch & Lomb
- UCBCares
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Retinal Drugs and Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Retinal Drugs and Biologics, with price, sales, revenue and global market share of Retinal Drugs and Biologics from 2019 to 2024.
Chapter 3, the Retinal Drugs and Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Retinal Drugs and Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Retinal Drugs and Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Retinal Drugs and Biologics.
Chapter 14 and 15, to describe Retinal Drugs and Biologics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Retinal Drugs and Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Age Related Macular Degeneration
1.3.3 Diabetic Retinopathy
1.3.4 Ocular Inflammatory Disease (Uveitis)
1.3.5 Macular Hole
1.4 Market Analysis by Application
1.4.1 Overview: Global Retinal Drugs and Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Retinal Drugs and Biologics Market Size & Forecast
1.5.1 Global Retinal Drugs and Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Retinal Drugs and Biologics Sales Quantity (2019-2030)
1.5.3 Global Retinal Drugs and Biologics Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 ALLERGAN
2.1.1 ALLERGAN Details
2.1.2 ALLERGAN Major Business
2.1.3 ALLERGAN Retinal Drugs and Biologics Product and Services
2.1.4 ALLERGAN Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 ALLERGAN Recent Developments/Updates
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Retinal Drugs and Biologics Product and Services
2.2.4 AbbVie Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AbbVie Recent Developments/Updates
2.3 Alimera Sciences
2.3.1 Alimera Sciences Details
2.3.2 Alimera Sciences Major Business
2.3.3 Alimera Sciences Retinal Drugs and Biologics Product and Services
2.3.4 Alimera Sciences Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Alimera Sciences Recent Developments/Updates
2.4 Janssen Biotech
2.4.1 Janssen Biotech Details
2.4.2 Janssen Biotech Major Business
2.4.3 Janssen Biotech Retinal Drugs and Biologics Product and Services
2.4.4 Janssen Biotech Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Janssen Biotech Recent Developments/Updates
2.5 Swedish Orphan Biovitrum
2.5.1 Swedish Orphan Biovitrum Details
2.5.2 Swedish Orphan Biovitrum Major Business
2.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product and Services
2.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Swedish Orphan Biovitrum Recent Developments/Updates
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Retinal Drugs and Biologics Product and Services
2.6.4 Roche Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Roche Recent Developments/Updates
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business
2.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Product and Services
2.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bristol-Myers Squibb Recent Developments/Updates
2.8 Genzyme
2.8.1 Genzyme Details
2.8.2 Genzyme Major Business
2.8.3 Genzyme Retinal Drugs and Biologics Product and Services
2.8.4 Genzyme Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Genzyme Recent Developments/Updates
2.9 Genentech
2.9.1 Genentech Details
2.9.2 Genentech Major Business
2.9.3 Genentech Retinal Drugs and Biologics Product and Services
2.9.4 Genentech Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Genentech Recent Developments/Updates
2.10 OCULAR THERAPEUTIX
2.10.1 OCULAR THERAPEUTIX Details
2.10.2 OCULAR THERAPEUTIX Major Business
2.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product and Services
2.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 OCULAR THERAPEUTIX Recent Developments/Updates
2.11 Bausch & Lomb
2.11.1 Bausch & Lomb Details
2.11.2 Bausch & Lomb Major Business
2.11.3 Bausch & Lomb Retinal Drugs and Biologics Product and Services
2.11.4 Bausch & Lomb Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bausch & Lomb Recent Developments/Updates
2.12 UCBCares
2.12.1 UCBCares Details
2.12.2 UCBCares Major Business
2.12.3 UCBCares Retinal Drugs and Biologics Product and Services
2.12.4 UCBCares Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 UCBCares Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RETINAL DRUGS AND BIOLOGICS BY MANUFACTURER
3.1 Global Retinal Drugs and Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Retinal Drugs and Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Retinal Drugs and Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Retinal Drugs and Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Retinal Drugs and Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Retinal Drugs and Biologics Manufacturer Market Share in 2023
3.5 Retinal Drugs and Biologics Market: Overall Company Footprint Analysis
3.5.1 Retinal Drugs and Biologics Market: Region Footprint
3.5.2 Retinal Drugs and Biologics Market: Company Product Type Footprint
3.5.3 Retinal Drugs and Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Retinal Drugs and Biologics Market Size by Region
4.1.1 Global Retinal Drugs and Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Retinal Drugs and Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Retinal Drugs and Biologics Average Price by Region (2019-2030)
4.2 North America Retinal Drugs and Biologics Consumption Value (2019-2030)
4.3 Europe Retinal Drugs and Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Retinal Drugs and Biologics Consumption Value (2019-2030)
4.5 South America Retinal Drugs and Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Retinal Drugs and Biologics Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
5.2 Global Retinal Drugs and Biologics Consumption Value by Type (2019-2030)
5.3 Global Retinal Drugs and Biologics Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
6.2 Global Retinal Drugs and Biologics Consumption Value by Application (2019-2030)
6.3 Global Retinal Drugs and Biologics Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
7.2 North America Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
7.3 North America Retinal Drugs and Biologics Market Size by Country
7.3.1 North America Retinal Drugs and Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Retinal Drugs and Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Retinal Drugs and Biologics Market Size by Country
8.3.1 Europe Retinal Drugs and Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Retinal Drugs and Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Retinal Drugs and Biologics Market Size by Region
9.3.1 Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Retinal Drugs and Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
10.2 South America Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
10.3 South America Retinal Drugs and Biologics Market Size by Country
10.3.1 South America Retinal Drugs and Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Retinal Drugs and Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Retinal Drugs and Biologics Market Size by Country
11.3.1 Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Retinal Drugs and Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Retinal Drugs and Biologics Market Drivers
12.2 Retinal Drugs and Biologics Market Restraints
12.3 Retinal Drugs and Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Retinal Drugs and Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Retinal Drugs and Biologics
13.3 Retinal Drugs and Biologics Production Process
13.4 Retinal Drugs and Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Retinal Drugs and Biologics Typical Distributors
14.3 Retinal Drugs and Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Retinal Drugs and Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Age Related Macular Degeneration
1.3.3 Diabetic Retinopathy
1.3.4 Ocular Inflammatory Disease (Uveitis)
1.3.5 Macular Hole
1.4 Market Analysis by Application
1.4.1 Overview: Global Retinal Drugs and Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Retinal Drugs and Biologics Market Size & Forecast
1.5.1 Global Retinal Drugs and Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Retinal Drugs and Biologics Sales Quantity (2019-2030)
1.5.3 Global Retinal Drugs and Biologics Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 ALLERGAN
2.1.1 ALLERGAN Details
2.1.2 ALLERGAN Major Business
2.1.3 ALLERGAN Retinal Drugs and Biologics Product and Services
2.1.4 ALLERGAN Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 ALLERGAN Recent Developments/Updates
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Retinal Drugs and Biologics Product and Services
2.2.4 AbbVie Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AbbVie Recent Developments/Updates
2.3 Alimera Sciences
2.3.1 Alimera Sciences Details
2.3.2 Alimera Sciences Major Business
2.3.3 Alimera Sciences Retinal Drugs and Biologics Product and Services
2.3.4 Alimera Sciences Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Alimera Sciences Recent Developments/Updates
2.4 Janssen Biotech
2.4.1 Janssen Biotech Details
2.4.2 Janssen Biotech Major Business
2.4.3 Janssen Biotech Retinal Drugs and Biologics Product and Services
2.4.4 Janssen Biotech Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Janssen Biotech Recent Developments/Updates
2.5 Swedish Orphan Biovitrum
2.5.1 Swedish Orphan Biovitrum Details
2.5.2 Swedish Orphan Biovitrum Major Business
2.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product and Services
2.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Swedish Orphan Biovitrum Recent Developments/Updates
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Retinal Drugs and Biologics Product and Services
2.6.4 Roche Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Roche Recent Developments/Updates
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business
2.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Product and Services
2.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bristol-Myers Squibb Recent Developments/Updates
2.8 Genzyme
2.8.1 Genzyme Details
2.8.2 Genzyme Major Business
2.8.3 Genzyme Retinal Drugs and Biologics Product and Services
2.8.4 Genzyme Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Genzyme Recent Developments/Updates
2.9 Genentech
2.9.1 Genentech Details
2.9.2 Genentech Major Business
2.9.3 Genentech Retinal Drugs and Biologics Product and Services
2.9.4 Genentech Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Genentech Recent Developments/Updates
2.10 OCULAR THERAPEUTIX
2.10.1 OCULAR THERAPEUTIX Details
2.10.2 OCULAR THERAPEUTIX Major Business
2.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product and Services
2.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 OCULAR THERAPEUTIX Recent Developments/Updates
2.11 Bausch & Lomb
2.11.1 Bausch & Lomb Details
2.11.2 Bausch & Lomb Major Business
2.11.3 Bausch & Lomb Retinal Drugs and Biologics Product and Services
2.11.4 Bausch & Lomb Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bausch & Lomb Recent Developments/Updates
2.12 UCBCares
2.12.1 UCBCares Details
2.12.2 UCBCares Major Business
2.12.3 UCBCares Retinal Drugs and Biologics Product and Services
2.12.4 UCBCares Retinal Drugs and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 UCBCares Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RETINAL DRUGS AND BIOLOGICS BY MANUFACTURER
3.1 Global Retinal Drugs and Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Retinal Drugs and Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Retinal Drugs and Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Retinal Drugs and Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Retinal Drugs and Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Retinal Drugs and Biologics Manufacturer Market Share in 2023
3.5 Retinal Drugs and Biologics Market: Overall Company Footprint Analysis
3.5.1 Retinal Drugs and Biologics Market: Region Footprint
3.5.2 Retinal Drugs and Biologics Market: Company Product Type Footprint
3.5.3 Retinal Drugs and Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Retinal Drugs and Biologics Market Size by Region
4.1.1 Global Retinal Drugs and Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Retinal Drugs and Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Retinal Drugs and Biologics Average Price by Region (2019-2030)
4.2 North America Retinal Drugs and Biologics Consumption Value (2019-2030)
4.3 Europe Retinal Drugs and Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Retinal Drugs and Biologics Consumption Value (2019-2030)
4.5 South America Retinal Drugs and Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Retinal Drugs and Biologics Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
5.2 Global Retinal Drugs and Biologics Consumption Value by Type (2019-2030)
5.3 Global Retinal Drugs and Biologics Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
6.2 Global Retinal Drugs and Biologics Consumption Value by Application (2019-2030)
6.3 Global Retinal Drugs and Biologics Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
7.2 North America Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
7.3 North America Retinal Drugs and Biologics Market Size by Country
7.3.1 North America Retinal Drugs and Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Retinal Drugs and Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Retinal Drugs and Biologics Market Size by Country
8.3.1 Europe Retinal Drugs and Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Retinal Drugs and Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Retinal Drugs and Biologics Market Size by Region
9.3.1 Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Retinal Drugs and Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
10.2 South America Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
10.3 South America Retinal Drugs and Biologics Market Size by Country
10.3.1 South America Retinal Drugs and Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Retinal Drugs and Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Retinal Drugs and Biologics Market Size by Country
11.3.1 Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Retinal Drugs and Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Retinal Drugs and Biologics Market Drivers
12.2 Retinal Drugs and Biologics Market Restraints
12.3 Retinal Drugs and Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Retinal Drugs and Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Retinal Drugs and Biologics
13.3 Retinal Drugs and Biologics Production Process
13.4 Retinal Drugs and Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Retinal Drugs and Biologics Typical Distributors
14.3 Retinal Drugs and Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Retinal Drugs and Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Retinal Drugs and Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. ALLERGAN Basic Information, Manufacturing Base and Competitors
Table 4. ALLERGAN Major Business
Table 5. ALLERGAN Retinal Drugs and Biologics Product and Services
Table 6. ALLERGAN Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. ALLERGAN Recent Developments/Updates
Table 8. AbbVie Basic Information, Manufacturing Base and Competitors
Table 9. AbbVie Major Business
Table 10. AbbVie Retinal Drugs and Biologics Product and Services
Table 11. AbbVie Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AbbVie Recent Developments/Updates
Table 13. Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table 14. Alimera Sciences Major Business
Table 15. Alimera Sciences Retinal Drugs and Biologics Product and Services
Table 16. Alimera Sciences Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Alimera Sciences Recent Developments/Updates
Table 18. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 19. Janssen Biotech Major Business
Table 20. Janssen Biotech Retinal Drugs and Biologics Product and Services
Table 21. Janssen Biotech Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Janssen Biotech Recent Developments/Updates
Table 23. Swedish Orphan Biovitrum Basic Information, Manufacturing Base and Competitors
Table 24. Swedish Orphan Biovitrum Major Business
Table 25. Swedish Orphan Biovitrum Retinal Drugs and Biologics Product and Services
Table 26. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Swedish Orphan Biovitrum Recent Developments/Updates
Table 28. Roche Basic Information, Manufacturing Base and Competitors
Table 29. Roche Major Business
Table 30. Roche Retinal Drugs and Biologics Product and Services
Table 31. Roche Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Roche Recent Developments/Updates
Table 33. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 34. Bristol-Myers Squibb Major Business
Table 35. Bristol-Myers Squibb Retinal Drugs and Biologics Product and Services
Table 36. Bristol-Myers Squibb Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Bristol-Myers Squibb Recent Developments/Updates
Table 38. Genzyme Basic Information, Manufacturing Base and Competitors
Table 39. Genzyme Major Business
Table 40. Genzyme Retinal Drugs and Biologics Product and Services
Table 41. Genzyme Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Genzyme Recent Developments/Updates
Table 43. Genentech Basic Information, Manufacturing Base and Competitors
Table 44. Genentech Major Business
Table 45. Genentech Retinal Drugs and Biologics Product and Services
Table 46. Genentech Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Genentech Recent Developments/Updates
Table 48. OCULAR THERAPEUTIX Basic Information, Manufacturing Base and Competitors
Table 49. OCULAR THERAPEUTIX Major Business
Table 50. OCULAR THERAPEUTIX Retinal Drugs and Biologics Product and Services
Table 51. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. OCULAR THERAPEUTIX Recent Developments/Updates
Table 53. Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table 54. Bausch & Lomb Major Business
Table 55. Bausch & Lomb Retinal Drugs and Biologics Product and Services
Table 56. Bausch & Lomb Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Bausch & Lomb Recent Developments/Updates
Table 58. UCBCares Basic Information, Manufacturing Base and Competitors
Table 59. UCBCares Major Business
Table 60. UCBCares Retinal Drugs and Biologics Product and Services
Table 61. UCBCares Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. UCBCares Recent Developments/Updates
Table 63. Global Retinal Drugs and Biologics Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 64. Global Retinal Drugs and Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Retinal Drugs and Biologics Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 66. Market Position of Manufacturers in Retinal Drugs and Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Retinal Drugs and Biologics Production Site of Key Manufacturer
Table 68. Retinal Drugs and Biologics Market: Company Product Type Footprint
Table 69. Retinal Drugs and Biologics Market: Company Product Application Footprint
Table 70. Retinal Drugs and Biologics New Market Entrants and Barriers to Market Entry
Table 71. Retinal Drugs and Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Retinal Drugs and Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 73. Global Retinal Drugs and Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 74. Global Retinal Drugs and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Retinal Drugs and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Retinal Drugs and Biologics Average Price by Region (2019-2024) & (USD/MT)
Table 77. Global Retinal Drugs and Biologics Average Price by Region (2025-2030) & (USD/MT)
Table 78. Global Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Global Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Global Retinal Drugs and Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Retinal Drugs and Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Retinal Drugs and Biologics Average Price by Type (2019-2024) & (USD/MT)
Table 83. Global Retinal Drugs and Biologics Average Price by Type (2025-2030) & (USD/MT)
Table 84. Global Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 85. Global Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 86. Global Retinal Drugs and Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Retinal Drugs and Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Retinal Drugs and Biologics Average Price by Application (2019-2024) & (USD/MT)
Table 89. Global Retinal Drugs and Biologics Average Price by Application (2025-2030) & (USD/MT)
Table 90. North America Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 91. North America Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 92. North America Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 93. North America Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 94. North America Retinal Drugs and Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 95. North America Retinal Drugs and Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 96. North America Retinal Drugs and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Retinal Drugs and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 99. Europe Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 100. Europe Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 101. Europe Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 102. Europe Retinal Drugs and Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 103. Europe Retinal Drugs and Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 104. Europe Retinal Drugs and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Retinal Drugs and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 107. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 108. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 111. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 112. Asia-Pacific Retinal Drugs and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Retinal Drugs and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 115. South America Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 116. South America Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 117. South America Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 118. South America Retinal Drugs and Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 119. South America Retinal Drugs and Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 120. South America Retinal Drugs and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Retinal Drugs and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 123. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 124. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 125. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 126. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 127. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 128. Middle East & Africa Retinal Drugs and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Retinal Drugs and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Retinal Drugs and Biologics Raw Material
Table 131. Key Manufacturers of Retinal Drugs and Biologics Raw Materials
Table 132. Retinal Drugs and Biologics Typical Distributors
Table 133. Retinal Drugs and Biologics Typical Customers
Table 1. Global Retinal Drugs and Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Retinal Drugs and Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. ALLERGAN Basic Information, Manufacturing Base and Competitors
Table 4. ALLERGAN Major Business
Table 5. ALLERGAN Retinal Drugs and Biologics Product and Services
Table 6. ALLERGAN Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. ALLERGAN Recent Developments/Updates
Table 8. AbbVie Basic Information, Manufacturing Base and Competitors
Table 9. AbbVie Major Business
Table 10. AbbVie Retinal Drugs and Biologics Product and Services
Table 11. AbbVie Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AbbVie Recent Developments/Updates
Table 13. Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table 14. Alimera Sciences Major Business
Table 15. Alimera Sciences Retinal Drugs and Biologics Product and Services
Table 16. Alimera Sciences Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Alimera Sciences Recent Developments/Updates
Table 18. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 19. Janssen Biotech Major Business
Table 20. Janssen Biotech Retinal Drugs and Biologics Product and Services
Table 21. Janssen Biotech Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Janssen Biotech Recent Developments/Updates
Table 23. Swedish Orphan Biovitrum Basic Information, Manufacturing Base and Competitors
Table 24. Swedish Orphan Biovitrum Major Business
Table 25. Swedish Orphan Biovitrum Retinal Drugs and Biologics Product and Services
Table 26. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Swedish Orphan Biovitrum Recent Developments/Updates
Table 28. Roche Basic Information, Manufacturing Base and Competitors
Table 29. Roche Major Business
Table 30. Roche Retinal Drugs and Biologics Product and Services
Table 31. Roche Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Roche Recent Developments/Updates
Table 33. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 34. Bristol-Myers Squibb Major Business
Table 35. Bristol-Myers Squibb Retinal Drugs and Biologics Product and Services
Table 36. Bristol-Myers Squibb Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Bristol-Myers Squibb Recent Developments/Updates
Table 38. Genzyme Basic Information, Manufacturing Base and Competitors
Table 39. Genzyme Major Business
Table 40. Genzyme Retinal Drugs and Biologics Product and Services
Table 41. Genzyme Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Genzyme Recent Developments/Updates
Table 43. Genentech Basic Information, Manufacturing Base and Competitors
Table 44. Genentech Major Business
Table 45. Genentech Retinal Drugs and Biologics Product and Services
Table 46. Genentech Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Genentech Recent Developments/Updates
Table 48. OCULAR THERAPEUTIX Basic Information, Manufacturing Base and Competitors
Table 49. OCULAR THERAPEUTIX Major Business
Table 50. OCULAR THERAPEUTIX Retinal Drugs and Biologics Product and Services
Table 51. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. OCULAR THERAPEUTIX Recent Developments/Updates
Table 53. Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table 54. Bausch & Lomb Major Business
Table 55. Bausch & Lomb Retinal Drugs and Biologics Product and Services
Table 56. Bausch & Lomb Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Bausch & Lomb Recent Developments/Updates
Table 58. UCBCares Basic Information, Manufacturing Base and Competitors
Table 59. UCBCares Major Business
Table 60. UCBCares Retinal Drugs and Biologics Product and Services
Table 61. UCBCares Retinal Drugs and Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. UCBCares Recent Developments/Updates
Table 63. Global Retinal Drugs and Biologics Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 64. Global Retinal Drugs and Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Retinal Drugs and Biologics Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 66. Market Position of Manufacturers in Retinal Drugs and Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Retinal Drugs and Biologics Production Site of Key Manufacturer
Table 68. Retinal Drugs and Biologics Market: Company Product Type Footprint
Table 69. Retinal Drugs and Biologics Market: Company Product Application Footprint
Table 70. Retinal Drugs and Biologics New Market Entrants and Barriers to Market Entry
Table 71. Retinal Drugs and Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Retinal Drugs and Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 73. Global Retinal Drugs and Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 74. Global Retinal Drugs and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Retinal Drugs and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Retinal Drugs and Biologics Average Price by Region (2019-2024) & (USD/MT)
Table 77. Global Retinal Drugs and Biologics Average Price by Region (2025-2030) & (USD/MT)
Table 78. Global Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Global Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Global Retinal Drugs and Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Retinal Drugs and Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Retinal Drugs and Biologics Average Price by Type (2019-2024) & (USD/MT)
Table 83. Global Retinal Drugs and Biologics Average Price by Type (2025-2030) & (USD/MT)
Table 84. Global Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 85. Global Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 86. Global Retinal Drugs and Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Retinal Drugs and Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Retinal Drugs and Biologics Average Price by Application (2019-2024) & (USD/MT)
Table 89. Global Retinal Drugs and Biologics Average Price by Application (2025-2030) & (USD/MT)
Table 90. North America Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 91. North America Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 92. North America Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 93. North America Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 94. North America Retinal Drugs and Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 95. North America Retinal Drugs and Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 96. North America Retinal Drugs and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Retinal Drugs and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 99. Europe Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 100. Europe Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 101. Europe Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 102. Europe Retinal Drugs and Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 103. Europe Retinal Drugs and Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 104. Europe Retinal Drugs and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Retinal Drugs and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 107. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 108. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 111. Asia-Pacific Retinal Drugs and Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 112. Asia-Pacific Retinal Drugs and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Retinal Drugs and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 115. South America Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 116. South America Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 117. South America Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 118. South America Retinal Drugs and Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 119. South America Retinal Drugs and Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 120. South America Retinal Drugs and Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Retinal Drugs and Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 123. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 124. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 125. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 126. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 127. Middle East & Africa Retinal Drugs and Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 128. Middle East & Africa Retinal Drugs and Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Retinal Drugs and Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Retinal Drugs and Biologics Raw Material
Table 131. Key Manufacturers of Retinal Drugs and Biologics Raw Materials
Table 132. Retinal Drugs and Biologics Typical Distributors
Table 133. Retinal Drugs and Biologics Typical Customers
LIST OF FIGURES
Figure 1. Retinal Drugs and Biologics Picture
Figure 2. Global Retinal Drugs and Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Retinal Drugs and Biologics Consumption Value Market Share by Type in 2023
Figure 4. Age Related Macular Degeneration Examples
Figure 5. Diabetic Retinopathy Examples
Figure 6. Ocular Inflammatory Disease (Uveitis) Examples
Figure 7. Macular Hole Examples
Figure 8. Global Retinal Drugs and Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Retinal Drugs and Biologics Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Others Examples
Figure 13. Global Retinal Drugs and Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Retinal Drugs and Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Retinal Drugs and Biologics Sales Quantity (2019-2030) & (K MT)
Figure 16. Global Retinal Drugs and Biologics Average Price (2019-2030) & (USD/MT)
Figure 17. Global Retinal Drugs and Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Retinal Drugs and Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Retinal Drugs and Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Retinal Drugs and Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Retinal Drugs and Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Retinal Drugs and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Retinal Drugs and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Retinal Drugs and Biologics Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Retinal Drugs and Biologics Average Price by Type (2019-2030) & (USD/MT)
Figure 32. Global Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Retinal Drugs and Biologics Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Retinal Drugs and Biologics Average Price by Application (2019-2030) & (USD/MT)
Figure 35. North America Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Retinal Drugs and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Retinal Drugs and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Retinal Drugs and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Retinal Drugs and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Retinal Drugs and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Retinal Drugs and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 55. China Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Retinal Drugs and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Retinal Drugs and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Retinal Drugs and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Retinal Drugs and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Retinal Drugs and Biologics Market Drivers
Figure 76. Retinal Drugs and Biologics Market Restraints
Figure 77. Retinal Drugs and Biologics Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Retinal Drugs and Biologics in 2023
Figure 80. Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure 81. Retinal Drugs and Biologics Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Retinal Drugs and Biologics Picture
Figure 2. Global Retinal Drugs and Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Retinal Drugs and Biologics Consumption Value Market Share by Type in 2023
Figure 4. Age Related Macular Degeneration Examples
Figure 5. Diabetic Retinopathy Examples
Figure 6. Ocular Inflammatory Disease (Uveitis) Examples
Figure 7. Macular Hole Examples
Figure 8. Global Retinal Drugs and Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Retinal Drugs and Biologics Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Others Examples
Figure 13. Global Retinal Drugs and Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Retinal Drugs and Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Retinal Drugs and Biologics Sales Quantity (2019-2030) & (K MT)
Figure 16. Global Retinal Drugs and Biologics Average Price (2019-2030) & (USD/MT)
Figure 17. Global Retinal Drugs and Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Retinal Drugs and Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Retinal Drugs and Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Retinal Drugs and Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Retinal Drugs and Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Retinal Drugs and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Retinal Drugs and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Retinal Drugs and Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Retinal Drugs and Biologics Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Retinal Drugs and Biologics Average Price by Type (2019-2030) & (USD/MT)
Figure 32. Global Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Retinal Drugs and Biologics Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Retinal Drugs and Biologics Average Price by Application (2019-2030) & (USD/MT)
Figure 35. North America Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Retinal Drugs and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Retinal Drugs and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Retinal Drugs and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Retinal Drugs and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Retinal Drugs and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Retinal Drugs and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 55. China Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Retinal Drugs and Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Retinal Drugs and Biologics Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Retinal Drugs and Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Retinal Drugs and Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Retinal Drugs and Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Retinal Drugs and Biologics Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Retinal Drugs and Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Retinal Drugs and Biologics Market Drivers
Figure 76. Retinal Drugs and Biologics Market Restraints
Figure 77. Retinal Drugs and Biologics Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Retinal Drugs and Biologics in 2023
Figure 80. Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure 81. Retinal Drugs and Biologics Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
